The $*** *******
****** *** **** * ****** ***** were ******, **** ************ ** ******** ****, ************ * $*** ******* ****** facility. ** *** * * **** term *** ** ********* ******** **** of ~*%. ** ** ******* **** 3 ********: $*** ******* *** ***********, $60 ******* *** ******* ******* *** $40 ******* *** *** *** ********* building.
**** ***********, ** *** *********** ****, Avigilon ** ******* ******* **** $** ******* to ***** *** ** *********** *****, which ************* ****** **** ********'* **** reserves. **** *********, *** **** ******** an ******** $** ******* ********** (***** would ***** *** ***** ** $*** million) *** **** ************.
Barriers ** ******
********* **** **** ***** ** ********'* last * **** ******. ** ******** 2013,******** ****** $** ********* $**.** *** *****. ** ***** 2014, ************** $*** ********* $** *** *****. *****, ********'* shares ***** ** $**.** *** *****.
******* ** *** **** *********** *** the *****'* ********* ** *** **** ****, ** ******* ** ***** **** been ***** **** *** ******** ** raise **** ***** ** ******* *** equity.
Pros *** **** ** *** $*** *******
**** ***** ** * *** ** money *** *** ************. ** *** end ** ****, ******** *** **** and **** *********** ** $**.* *******. Now **** **** *** $** ******* 'back' **** *** ** ********, **** $20 ******* **** *********** ********* ** credit *** ************, **** *** $** million ******. *** ** **** **** Avigilon ** ********** ** ********* **** fairly ******** ******** ** ************ *********.
**** ******** ** **** *** **** ** quite ***, ********** ***** ** ******** ******* for ********* ** ***** ** ****** enforcement.
*** *** ******** ** *** * year ****. ** ****** ** **** for ********, **** *** ****** ****** the ****** ****. ** ****** ** really ****, **** *** ***** ******. However, ** ******** **** ******** ** there ** * *********, ******** **** have ************ ******* ****, ***** ***** put **** ******** ** *** ********.
Who **** **** *** ****?
*** ***, ******, **** ** * pretty ***** ********* **** ******** **** continue ** ** ********** *** ** likely ** *** **** ********* ** the **** ****.